Context:
US pharma giant Eli Lilly, which plans to bring its obesity and diabetes drug Tirzepatide (or Mounjaro) to India next year.
About the Drug:
- Tirzepatide is an antidiabetic medication used for the treatment of type 2 diabetes and for weight loss. Tirzepatide is administered via subcutaneous injections (under the skin).
- It is sold under the brand names Mounjaro for diabetes treatment, and Zepbound for weight loss.
Drug Composition:
Tirzepatide is a linear polypeptide of 39 amino acids that has been chemically modified by lipidation to improve its uptake into cells and its stability to metabolism.
Eli Lilly:
Eli Lilly is a pharmaceutical company that was founded by Colonel Eli Lilly, a Union Army veteran and pharmaceutical chemist, in 1876.
